It is noteworthy that the administration of oligomycin, a specific inhibitor that suppresses cellular OXPHOS by targeting the F0/F1 ATPase complex,[14] impaired both the stemness and cisplatin resistance in T24 and UMUC3 cells (Figure S1C–F, Supporting Information), as well as their corresponding CIS cell lines (Figure S1G–J, Supporting Information). The gene discussed is DNAH8; the disease is in situ carcinoma.